Prominent gaps in pediatric and adolescent HIV care translate into priorities that need to be addressed for optimizing care ...

A peer reviewer questioned the premise of our study into the potential impact of abruptly ending PEPFAR funding. Then it ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...

Doctors, clinical officers, nurses, laboratory technologists, pharmacists, community health workers and staff funded by the US Government have been impacted. Service Disruptions: Some facilities ...

HIV Testing and Outreach: 90% reduction for key populations, affecting four HIV-servicing NGOs in two regions. These regions account for 20% of the population of people who use drugs and 9% of the ...

The cancellation of USAID contracts has threatened critical global health research. Plus, new guidance to prevent HIV in ...

The withdrawal of Pepfar funding has left organisations grappling with devastating consequences, as two key players share ...

In the general population, frailty is an aging-related risk factor for poor outcomes; individuals experiencing frailty face ...

Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But ...

David Furnish’s leadership at EJAF proves brands can do more than raise awareness —they can dismantle stigma and drive systemic change in the fight against HIV/AIDS.